Tag: Cabtreo

Acne vulgaris is a common skin condition affecting millions of people [1.7.5]. For those prescribed the triple-action gel Cabtreo, a primary question is: **how long does it take to see results from Cabtreo?** [1.2.1, 1.6.2]

The U.S. Food and Drug Administration (FDA) approved Cabtreo in October 2023, the first triple-combination topical gel for acne [1.2.9]. This raises a key question for many: **Is Cabtreo better than tretinoin**, a long-established standard in acne treatment? [1.5.3]

Approved by the FDA in October 2023, CABTREO is the first and only fixed-dose, triple-combination topical gel for treating acne vulgaris. It is indicated for use in adult and pediatric patients aged 12 years and older who have moderate to severe acne.

In recent clinical trials, approximately 50% of people using Cabtreo achieved clear or almost clear skin after 12 weeks of treatment. Cabtreo is the first FDA-approved fixed-dose triple-combination topical gel used to treat moderate-to-severe acne vulgaris in patients 12 years of age and older.